AuditLine › HHS OIG › Centers for Medicare and Medicaid Services
HHS OIG recommendation 23-A-04-050.02
We recommend that the Florida Agency for Health Care Administration work with CMS to determine whether the other claims for multiple-source…
The recommendation, in the publisher's words
We recommend that the Florida Agency for Health Care Administration work with CMS to determine whether the other claims for multiple-source physician-administered drugs, totaling $40,635 ($24,772 Federal share), were eligible for rebates and, if so, determine the rebates due and, upon receipt of the rebates, refund the Federal share of the rebates collected.
- Responsible agency
- Centers for Medicare and Medicaid Services
- Issued
- March 3, 2023
- Report
- Florida Did Not Invoice Manufacturers for Some Rebates for Physician-Administered Drugs Dispensed to Enrollees of Medicaid Managed-Care Organizations (A-04-21-07098) · find it at HHS OIG
- Kind of report
- Audit
- Agency response
- Concur (as recorded by the publisher)
- Closed
- August 24, 2023 (publisher's date)
- Potential savings
- $24,772 (the publisher's figure; not realised savings)
- Publisher topics
- Financial Stewardship, Prescription Drug
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- Closed, with status “Closed Implemented”. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Other recommendations from this report
2 more, of which 0 are open in the publisher's file.
- We recommend that the Florida Agency for Health Care Administration invoice for, and collect from manufacturers, an estimated $57,700 ($35,126 Federal share) in rebates for single-source…HHS OIG 23-A-04-050.01 · issued Mar 3, 2023 · closed Feb 8, 2024Closed Implemented
- We recommend that the Florida Agency for Health Care Administration ensure that all physician-administered drugs eligible for rebates after our audit period are processed for rebates.HHS OIG 23-A-04-050.03 · issued Mar 3, 2023 · closed Jun 25, 2025Closed Implemented
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.